Array BioPharma Inc.’s $259 Million Initial Public Offering

Ambrogio Visconti

Ballard Spahr represented Array BioPharma Inc. (Nasdaq: ARRY), in the recent closing of a public offering by the biopharmaceutical company, which generated total gross proceeds of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here